TY - JOUR AU - Small, W. AU - Bacon, M. A. AU - Bajaj, A. AU - Chuang, L. T. AU - Fisher, B. J. AU - Harkenrider, M. M. PY - 2017 DA - 2017// TI - Cervical cancer: A global health crisis JO - Cancer VL - 123 UR - https://doi.org/10.1002/cncr.30667 DO - 10.1002/cncr.30667 ID - Small2017 ER - TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Keshavarz, M. AU - Nejad, A. S. M. AU - Esghaei, M. AU - Bokharaei-Salim, F. AU - Dianat-Moghadam, H. AU - Keyvani, H. PY - 2019 DA - 2019// TI - Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis JO - Saudi J Biol Sci. VL - 27 ID - Keshavarz2019 ER - TY - JOUR AU - Ajina, A. AU - Maher, J. PY - 2019 DA - 2019// TI - Synergistic combination of oncolytic virotherapy with CAR T-cell therapy JO - Cancer Immunother. VL - 164 UR - https://doi.org/10.1016/bs.pmbts.2019.06.015 DO - 10.1016/bs.pmbts.2019.06.015 ID - Ajina2019 ER - TY - JOUR AU - Tahamtan, A. AU - Barati, M. AU - Tabarraei, A. AU - Mohebbi, S. R. AU - Shirian, S. AU - Gorji, A. PY - 2018 DA - 2018// TI - Antitumor immunity induced by genetic immunization with Chitosan nanoparticle formulated adjuvanted for HPV-16 E7 DNA vaccine JO - Iran J Immunol VL - 15 ID - Tahamtan2018 ER - TY - JOUR AU - Moeini, S. AU - Saeidi, M. AU - Fotouhi, F. AU - Mondanizadeh, M. AU - Shirian, S. AU - Mohebi, A. PY - 2017 DA - 2017// TI - Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine JO - Arch Virol VL - 162 UR - https://doi.org/10.1007/s00705-016-3091-5 DO - 10.1007/s00705-016-3091-5 ID - Moeini2017 ER - TY - JOUR AU - Borcoman, E. AU - Tourneau, C. PY - 2017 DA - 2017// TI - Pembrolizumab in cervical cancer: latest evidence and clinical usefulness JO - Ther Adv Med Oncol VL - 9 UR - https://doi.org/10.1177/1758834017708742 DO - 10.1177/1758834017708742 ID - Borcoman2017 ER - TY - JOUR AU - Liu, Y. L. AU - Zamarin, D. PY - 2018 DA - 2018// TI - Combination immune checkpoint blockade strategies to maximize immune response in gynecological cancers JO - Curr Oncol Rep VL - 20 UR - https://doi.org/10.1007/s11912-018-0740-8 DO - 10.1007/s11912-018-0740-8 ID - Liu2018 ER - TY - JOUR AU - Keshavarz, M. AU - Solaymani-Mohammadi, F. AU - Miri, S. M. AU - Ghaemi, A. PY - 2019 DA - 2019// TI - Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy JO - J Biomed Sci VL - 26 UR - https://doi.org/10.1186/s12929-019-0542-9 DO - 10.1186/s12929-019-0542-9 ID - Keshavarz2019 ER - TY - JOUR AU - Brown, C. AU - King, D. J. AU - Seal, B. S. PY - 1999 DA - 1999// TI - Pathogenesis of newcastle disease in chickens experimentally infected with viruses of different virulence JO - Vet Pathol VL - 36 UR - https://doi.org/10.1354/vp.36-2-125 DO - 10.1354/vp.36-2-125 ID - Brown1999 ER - TY - JOUR AU - Visnuvinayagam, S. AU - K, T. AU - Sukumar, N. L. S. M. PY - 2015 DA - 2015// TI - Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov JO - Brazilian J Microbiol VL - 46 UR - https://doi.org/10.1590/S1517-838246320140051 DO - 10.1590/S1517-838246320140051 ID - Visnuvinayagam2015 ER - TY - JOUR AU - Fu, X. AU - Tao, L. AU - Jin, A. AU - Vile, R. AU - Brenner, M. K. AU - Zhang, X. PY - 2003 DA - 2003// TI - Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect JO - Mol Ther VL - 7 UR - https://doi.org/10.1016/S1525-0016(03)00092-3 DO - 10.1016/S1525-0016(03)00092-3 ID - Fu2003 ER - TY - JOUR AU - Burton, C. AU - Bartee, E. PY - 2019 DA - 2019// TI - Syncytia formation in oncolytic virotherapy JO - Mol Ther Oncol VL - 15 UR - https://doi.org/10.1016/j.omto.2019.09.006 DO - 10.1016/j.omto.2019.09.006 ID - Burton2019 ER - TY - JOUR AU - Michiue, H. AU - Tomizawa, K. AU - Wei, F. Y. AU - Matsushita, M. AU - Lu, Y. F. AU - Ichikawa, T. PY - 2005 DA - 2005// TI - The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M412430200 DO - 10.1074/jbc.M412430200 ID - Michiue2005 ER - TY - JOUR AU - Ahmed, A. AU - Jevremovic, D. AU - Suzuki, K. AU - Kottke, T. AU - Thompson, J. AU - Emery, S. PY - 2003 DA - 2003// TI - Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy JO - Gene Ther VL - 10 UR - https://doi.org/10.1038/sj.gt.3302064 DO - 10.1038/sj.gt.3302064 ID - Ahmed2003 ER - TY - JOUR AU - Bateman, A. R. AU - Harrington, K. J. AU - Kottke, T. AU - Ahmed, A. AU - Melcher, A. A. AU - Gough, M. J. PY - 2002 DA - 2002// TI - Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells JO - Cancer Res VL - 62 ID - Bateman2002 ER - TY - JOUR AU - Nakamori, M. AU - Fu, X. AU - Meng, F. AU - Jin, A. AU - Tao, L. AU - Bast, R. C. PY - 2003 DA - 2003// TI - Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms JO - Clin Cancer Res VL - 9 ID - Nakamori2003 ER - TY - JOUR AU - Mohebbi, A. AU - Ebrahimzadeh, M. S. AU - Baghban Rahimi, S. AU - Saeidi, M. AU - Tabarraei, A. AU - Mohebbi, S. R. PY - 2019 DA - 2019// TI - Non-replicating Newcastle disease virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression JO - Virus Res. VL - 261 UR - https://doi.org/10.1016/j.virusres.2018.12.014 DO - 10.1016/j.virusres.2018.12.014 ID - Mohebbi2019 ER - TY - JOUR AU - Ghrici, M. AU - EL Zowalaty, M. AU - Omar, A. R. AU - Ideris, A. PY - 2013 DA - 2013// TI - Newcastle disease virus Malaysian strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early stage of the virus life cycle JO - Int J Mol Med VL - 31 UR - https://doi.org/10.3892/ijmm.2013.1244 DO - 10.3892/ijmm.2013.1244 ID - Ghrici2013 ER - TY - JOUR AU - Ahmed, S. R. AU - Nagy, É. AU - Neethirajan, S. PY - 2017 DA - 2017// TI - Self-assembled star-shaped chiroplasmonic gold nanoparticles for an ultrasensitive chiro-immunosensor for viruses JO - RSC Adv VL - 7 UR - https://doi.org/10.1039/C7RA07175B DO - 10.1039/C7RA07175B ID - Ahmed2017 ER - TY - JOUR AU - Jalili, N. AU - Taheri, N. AU - Tavakoli, R. AU - Fotoohi, F. AU - Akbari, A. AU - Farahmand, B. PY - 2016 DA - 2016// TI - Expression and purification of a recombinant chimeric protein (3M2e-HA2) composed of influenza virus hemaglutinin and matrix protein conserved domain for universal subunit vaccine development JO - J Maz Univ Med Sci VL - 26 ID - Jalili2016 ER - TY - JOUR AU - Ghaemi, A. AU - Soleimanjahi, H. AU - Razeghi, S. AU - Gorji, A. AU - Tabaraei, A. AU - Moradi, A. PY - 2012 DA - 2012// TI - Genistein induces a protective immunomodulatory effect in a mouse model of cervical cancer JO - Iran J Immunol VL - 9 ID - Ghaemi2012 ER - TY - JOUR AU - Berger, C. L. AU - Tigelaar, R. AU - Cohen, J. AU - Mariwalla, K. AU - Trinh, J. AU - Wang, N. PY - 2005 DA - 2005// TI - Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-06-2181 DO - 10.1182/blood-2004-06-2181 ID - Berger2005 ER - TY - JOUR AU - Davola, M. E. AU - Mossman, K. L. PY - 2019 DA - 2019// TI - Oncolytic viruses: how “lytic” must they be for therapeutic efficacy? JO - Oncoimmunology VL - 8 UR - https://doi.org/10.1080/2162402X.2019.1596006 DO - 10.1080/2162402X.2019.1596006 ID - Davola2019 ER - TY - JOUR AU - Kim, B. AU - Srivastava, S. K. AU - Kim, S. -. H. PY - 2015 DA - 2015// TI - Caspase-9 as a therapeutic target for treating cancer JO - Expert Opin Ther Targets VL - 19 UR - https://doi.org/10.1517/14728222.2014.961425 DO - 10.1517/14728222.2014.961425 ID - Kim2015 ER - TY - JOUR AU - Kim, E. -. J. AU - Kang, C. -. W. AU - Kim, N. -. H. AU - Seo, Y. B. AU - Nam, S. -. W. AU - Kim, G. -. D. PY - 2018 DA - 2018// TI - Induction of apoptotic cell death on human cervix cancer HeLa cells by extract from Loranthus yadoriki JO - Biotechnol Bioprocess Eng VL - 23 UR - https://doi.org/10.1007/s12257-018-0033-y DO - 10.1007/s12257-018-0033-y ID - Kim2018 ER - TY - JOUR AU - Wang, B. AU - Yan, X. AU - Guo, Q. AU - Li, Y. AU - Zhang, H. AU - Xie, J. PY - 2015 DA - 2015// TI - Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3496 DO - 10.18632/oncotarget.3496 ID - Wang2015 ER - TY - JOUR AU - Hu, L. AU - Sun, S. AU - Wang, T. AU - Li, Y. AU - Jiang, K. AU - Lin, G. PY - 2015 DA - 2015// TI - Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy JO - Am J Cancer Res VL - 5 ID - Hu2015 ER - TY - JOUR AU - Garris, C. S. AU - Arlauckas, S. P. AU - Kohler, R. H. AU - Trefny, M. P. AU - Garren, S. AU - Piot, C. PY - 2018 DA - 2018// TI - Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 JO - Immunity VL - 49 UR - https://doi.org/10.1016/j.immuni.2018.09.024 DO - 10.1016/j.immuni.2018.09.024 ID - Garris2018 ER - TY - JOUR AU - Ylösmäki, E. AU - Cerullo, V. PY - 2020 DA - 2020// TI - Design and application of oncolytic viruses for cancer immunotherapy JO - Curr Opin Biotechnol VL - 65 UR - https://doi.org/10.1016/j.copbio.2019.11.016 DO - 10.1016/j.copbio.2019.11.016 ID - Ylösmäki2020 ER - TY - JOUR AU - Russell, S. J. AU - Peng, K. -. W. PY - 2007 DA - 2007// TI - Viruses as anticancer drugs JO - Trends Pharmacol Sci VL - 28 UR - https://doi.org/10.1016/j.tips.2007.05.005 DO - 10.1016/j.tips.2007.05.005 ID - Russell2007 ER - TY - JOUR AU - Martin, N. T. AU - Bell, J. C. PY - 2018 DA - 2018// TI - Oncolytic virus combination therapy: killing one bird with two stones JO - Mol Ther VL - 26 UR - https://doi.org/10.1016/j.ymthe.2018.04.001 DO - 10.1016/j.ymthe.2018.04.001 ID - Martin2018 ER - TY - JOUR AU - Thorne, S. AU - Bartlett, D. AU - Kirn, D. PY - 2005 DA - 2005// TI - The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally? JO - Curr Gene Ther VL - 5 UR - https://doi.org/10.2174/1566523054546215 DO - 10.2174/1566523054546215 ID - Thorne2005 ER - TY - JOUR AU - Higuchi, H. AU - Bronk, S. F. AU - Bateman, A. AU - Harrington, K. AU - Vile, R. G. AU - Gores, G. J. PY - 2000 DA - 2000// TI - Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy JO - Cancer Res VL - 60 ID - Higuchi2000 ER - TY - JOUR AU - Galanis, E. AU - Bateman, A. AU - Johnson, K. AU - Diaz, R. M. AU - James, C. D. AU - Vile, R. PY - 2001 DA - 2001// TI - Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas JO - Hum Gene Ther VL - 12 UR - https://doi.org/10.1089/104303401750148766 DO - 10.1089/104303401750148766 ID - Galanis2001 ER - TY - JOUR AU - Hoffmann, D. PY - 2006 DA - 2006// TI - Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0128 DO - 10.1158/1535-7163.MCT-06-0128 ID - Hoffmann2006 ER - TY - JOUR AU - Hoffmann, D. AU - Bangen, J. -. M. AU - Bayer, W. AU - Wildner, O. PY - 2006 DA - 2006// TI - Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer JO - Gene Ther VL - 13 UR - https://doi.org/10.1038/sj.gt.3302806 DO - 10.1038/sj.gt.3302806 ID - Hoffmann2006 ER - TY - JOUR AU - Hoffmann, D. AU - Grunwald, T. AU - Kuate, S. AU - Wildner, O. PY - 2007 DA - 2007// TI - Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy JO - Cancer Biol Ther VL - 6 UR - https://doi.org/10.4161/cbt.6.4.3815 DO - 10.4161/cbt.6.4.3815 ID - Hoffmann2007 ER - TY - JOUR AU - Wildner, O. AU - Bayer, W. AU - Hoffmann, D. PY - 2007 DA - 2007// TI - Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors JO - Int J Mol Med VL - 20 ID - Wildner2007 ER - TY - JOUR AU - Errington, F. AU - Jones, J. AU - Merrick, A. AU - Bateman, A. AU - Harrington, K. AU - Gough, M. PY - 2006 DA - 2006// TI - Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming JO - Gene Ther VL - 13 UR - https://doi.org/10.1038/sj.gt.3302609 DO - 10.1038/sj.gt.3302609 ID - Errington2006 ER - TY - JOUR AU - Nardacci, R. AU - Perfettini, J. -. L. AU - Grieco, L. AU - Thieffry, D. AU - Kroemer, G. AU - Piacentini, M. PY - 2015 DA - 2015// TI - Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview JO - Cell Death Dis VL - 6 UR - https://doi.org/10.1038/cddis.2015.204 DO - 10.1038/cddis.2015.204 ID - Nardacci2015 ER - TY - JOUR AU - Linardakis, E. AU - Bateman, A. AU - Phan, V. AU - Ahmed, A. AU - Gough, M. AU - Olivier, K. PY - 2002 DA - 2002// TI - Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion JO - Cancer Res VL - 62 ID - Linardakis2002 ER - TY - JOUR AU - Ganar, K. AU - Das, M. AU - Sinha, S. AU - Kumar, S. PY - 2014 DA - 2014// TI - Newcastle disease virus: Current status and our understanding JO - Virus Res VL - 184 UR - https://doi.org/10.1016/j.virusres.2014.02.016 DO - 10.1016/j.virusres.2014.02.016 ID - Ganar2014 ER - TY - JOUR AU - Bai, F. -. L. AU - Yu, Y. -. H. AU - Tian, H. AU - Ren, G. -. P. AU - Wang, H. AU - Zhou, B. PY - 2014 DA - 2014// TI - Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy JO - Cancer Biol Ther VL - 15 UR - https://doi.org/10.4161/cbt.29686 DO - 10.4161/cbt.29686 ID - Bai2014 ER - TY - JOUR AU - Elankumaran, S. AU - Rockemann, D. AU - Samal, S. K. PY - 2006 DA - 2006// TI - Newcastle disease virus exerts oncolysis by both Intrinsic and extrinsic caspase-dependent pathways of cell death JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.00241-06 DO - 10.1128/JVI.00241-06 ID - Elankumaran2006 ER - TY - JOUR AU - Ward, T. H. AU - Cummings, J. AU - Dean, E. AU - Greystoke, A. AU - Hou, J. M. AU - Backen, A. PY - 2008 DA - 2008// TI - Biomarkers of apoptosis JO - Br J Cancer VL - 99 UR - https://doi.org/10.1038/sj.bjc.6604519 DO - 10.1038/sj.bjc.6604519 ID - Ward2008 ER - TY - JOUR AU - Ravindra, P. V. AU - Tiwari, A. K. AU - Ratta, B. AU - Chaturvedi, U. AU - Palia, S. K. AU - Chauhan, R. S. PY - 2009 DA - 2009// TI - Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis JO - Virus Res VL - 141 UR - https://doi.org/10.1016/j.virusres.2008.12.008 DO - 10.1016/j.virusres.2008.12.008 ID - Ravindra2009 ER - TY - JOUR AU - Ren, S. AU - Rehman, Z. U. AU - Shi, M. AU - Yang, B. AU - Liu, P. AU - Yin, Y. PY - 2019 DA - 2019// TI - Hemagglutinin-neuraminidase and fusion proteins of virulent Newcastle disease virus cooperatively disturb fusion–fission homeostasis to enhance mitochondrial function by activating the unfolded protein response of endoplasmic reticulum and mitochondrial s JO - Vet Res VL - 50 UR - https://doi.org/10.1186/s13567-019-0654-y DO - 10.1186/s13567-019-0654-y ID - Ren2019 ER - TY - JOUR AU - Smith, E. C. AU - Popa, A. AU - Chang, A. AU - Masante, C. AU - Dutch, R. E. PY - 2009 DA - 2009// TI - Viral entry mechanisms: the increasing diversity of paramyxovirus entry JO - FEBS J VL - 276 UR - https://doi.org/10.1111/j.1742-4658.2009.07401.x DO - 10.1111/j.1742-4658.2009.07401.x ID - Smith2009 ER - TY - JOUR AU - Altomonte, J. AU - Marozin, S. AU - Schmid, R. M. AU - Ebert, O. PY - 2010 DA - 2010// TI - Engineered Newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2009.231 DO - 10.1038/mt.2009.231 ID - Altomonte2010 ER - TY - JOUR AU - Zamarin, D. AU - Ricca, J. M. AU - Sadekova, S. AU - Oseledchyk, A. AU - Yu, Y. AU - Blumenschein, W. M. PY - 2018 DA - 2018// TI - PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI98047 DO - 10.1172/JCI98047 ID - Zamarin2018 ER -